Contact Us
  • Choose License Type

3D cell culturing using scaffolds is the conventional and most widely used technique. Scaffolds support growth of the cells. They are divided into two types, namely, natural scaffolds and artificial scaffolds. Natural scaffolds can be developed from human ECM or animal ECM. Artificial scaffolds can be made up of metals, ceramics, and polymers.

Statistics:

The global 3D cell culture market is estimated to account for US$ 2,717.6 Mn in terms of value by the end of 2020.

Global 3D Cell Culture Market: Drivers

Increasing demand for organ transplant is expected to propel growth of the global 3D cell culture market over the forecast period. For instance, according to the U.S. Government Information on Organ Donation and Transplantation, over 112,000 patients are on the national transplant waiting list as of March 2020.

Global 3D Cell Culture Market: Opportunities

Increasing focus on regenerative medicines is expected to offer lucrative growth opportunities for players in the global 3D cell culture market. In the past few years, the regenerative medicine field has attracted huge attention due to its ability to treat or replace damaged tissues and body parts. Owing to these advantages, there has been an incessant rise in the investments made in this field.

Global 3D Cell Culture Market: Restraints

Budgetary constraints faced by small and medium sized laboratories is a major restraining factor for growth of the global 3D cell culture market. The switching cost of a laboratory from a 2D cell culture setup to 3D cell culture setup is very high. Furthermore, a high level of accuracy is required for 3D cell culturing due to which various researchers are opting for automated systems. The cost of laboratory automation may range up to US$ 1 Mn, depending upon the level of automation that the laboratory opts for. It becomes difficult for a small laboratory to justify such a large investment.

Key Takeaways:

The global 3D cell culture market was valued at US$ 2,093.7 Mn in 2019 and is forecast to reach a value of US$ 16,270.5 Mn by 2027 at a CAGR of 29.1% between 2020 and 2027. Increasing demand for organ transplant is expected to propel growth of the global 3D cell culture market over the forecast period.

Extracellular Matrices or Scaffolds segment held dominant position in the global 3D cell culture market in 2019, accounting for 39.6% share in terms of value, increasing technological advancements and increasing prevalence of chronic diseases is expected to drive the market growth.

Market Trends

Emergence of Covid-19 is expected to propel growth of the global 3D cell culture market. For instance, globally, as of 3:52pm CEST, 28 September 2020, there have been 33,034,598 confirmed cases of COVID-19, including 996,342 deaths, reported to the World Health Organization.

Major players in the global 3D cell culture market are focused on launching new products to expand their product portfolio. For instance, in August 2020, Corning Incorporated launched 3D Clear Tissue Clearing Reagent, designed for rapid and easy imaging of tissues in 3D cell culture without damaging the underlying cellular morphology.

Global 3D Cell Culture Market: Competitive Landscape   

Major players operating in the global 3D cell culture market include, Becton, Dickinson and Company, Corning Incorporated, Lonza Group, Thermo Fisher Scientific, Inc., 3D Biotek LLC, 3D Biomatrix, Inc., Global Cell Solutions, Inc., InSphero AG, Sigma-Aldrich Corporation (a subsidiary of Merck KGaA), and Reinnervate Ltd. (a subsidiary of ReproCELL).

Global 3D Cell Culture Market: Key Developments

Major players in the global 3D cell culture market are focused on launching new products to expand their product portfolio. For instance, in June 2020, Corning Incorporated launched Corning Matrigel matrix-3D plates, pre-dispensed with Matrigel matrix to provide a more consistent and convenient, ready-to-use cell culture option to support organoid and spheroid culture models.

To know the latest trends and insights prevalent in the Global 3D Cell Culture Market, click the link below:

https://www.coherentmarketinsights.com/market-insight/3d-cell-culture-market-534

Segmentation

Scope of the report

  • Global 3D Cell Culture Market, By Technology:
    • Extracellular Matrices or Scaffolds
    • Bioreactors
    • Gels
    • Scaffold-free platforms
    • Microchips
  • Global 3D Cell Culture Market, By Application:
    • Research
    • Drug Discovery
    • Tissue Engineering
    • Clinical Applications
    • Stem Cell Biology
  • Global 3D Cell Culture Market, By End User:
    • Research Labs & Institutes
    • Biopharmaceutical Industry
    • Hospitals and diagnostic centers
    • Others
  • Global 3D Cell Culture Market, By Region:
    • North America
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • U.K.
        • Germany
        • France
        • Spain
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • China
        • Japan
        • India
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • By Technology:
        • Extracellular Matrices or Scaffolds
        • Bioreactors
        • Gels
        • Scaffold-free platforms
        • Microchips
      • By Application
        • Research
        • Drug Discovery
        • Tissue Engineering
        • Clinical Applications
        • Stem Cell Biology
      • By End User
        • Research Labs & Institutes
        • Biopharmaceutical Industry
        • Hospitals and diagnostic centers
        • Others
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Becton, Dickinson and Company *
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Lonza Group
    • Thermo Fisher Scientific, Inc.
    • Corning Incorporated
    • 3D Biotek LLC
    • 3D Biomatrix, Inc.
    • Global Cell Solutions, Inc.
    • InSphero AG
    • Sigma-Aldrich Corporation (a subsidiary of Merck KGaA)
    • Reinnervate Ltd. (a subsidiary of ReproCELL)
  •  “*” marked represents similar segmentation in other categories in the respective section.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner